| FDA Adds Plasma as 2nd COVID-19 Treatment Under Emergency Guidelines | Sarah de Crescenzo | 08/24/20 | National |
| Moderna, Pfizer Protocols May Make COVID Vaccines Hard to Compare | Sarah Karlin-Smith | 08/07/20 | National |
| FDA Welcomes Variety of Phase 2/3 Trial Designs for COVID-19 Therapies | Bridget Silverman | 05/28/20 | National |
| Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More | Frank Vinluan | 04/24/20 | National |
| Fears Of Recession Mount As Coronavirus Declared A Pandemic | Andrew McConaghie | 03/19/20 | National |
| Bio Roundup: Pandemic Declared, Rubius Restarts, Kymera’s Cash & More | Frank Vinluan | 03/13/20 | National |
| Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug | Frank Vinluan | 10/31/19 | Boston |
| Salk Team Awarded 8-Year, $19.2M Grant for Alzheimer’s Research | Sarah de Crescenzo | 11/09/18 | San Diego |
| NIH Using Vaccines from Madison Startup FluGen in New Clinical Trial | Jeff Buchanan | 09/19/18 | Wisconsin |
| Arrowhead Shares Pop on Early Clinical Data for Hepatitis B Drug | Jeff Buchanan | 09/06/18 | Wisconsin |
| FluGen to Study Versatility of Its Universal Flu Vaccine Candidate | Jeff Buchanan | 05/17/18 | Wisconsin |
| Bio Roundup: Graham-Cassidy, Axovant Fail, SpringWorks Launches & More | Frank Vinluan | 09/29/17 | National |
| FluGen, Startup Developing Universal Flu Vaccine, Raises $5.5M | Jeff Buchanan | 08/01/17 | Wisconsin |
| Goldman Funnels $51M Into Cloud Tech Company That Fights Fake Drugs | David Holley | 11/30/16 | Boston |
| Eli Lilly Commits $15M More to Seattle Institute’s TB Drug Search | Frank Vinluan | 10/18/16 | Indiana |
| FluGen Starts Clinical Trial for Universal Flu Vaccine | Jeff Buchanan | 07/27/16 | Wisconsin |
| The Outbreaks Are Here, Where’s Our Response Plan? | Steve Reed | 07/25/16 | Seattle |
| Titan Spine CEO: New Medical Billing Code Will Be ‘Big Selling Point’ | Jeff Buchanan | 07/19/16 | Wisconsin |
| Genocea Ditches Pneumococcus Vaccine After Phase 2 Flop, Shares Fall | Ben Fidler | 10/19/15 | Boston |
| “Global Health” Must Mean Global Health | Erik Iverson | 07/09/15 | Seattle |
| WHO Approves 15-Minute Ebola Test Developed by Corgenix | Michael Davidson | 02/20/15 | Boulder/Denver |
| Vaxxas Gets $20M Injection to Test Needle-Free Vaccines in Humans | Ben Fidler | 02/09/15 | Boston |
| Beg, Borrow, or Steal: Accessing Unaffordable Science Journals | Stewart Lyman | 11/10/14 | National |
| J&J, GSK, Tekmira, And Others Take Next Steps To Fight Ebola | Alex Lash | 10/22/14 | Boston |
| An Intriguing Program Takes on Tropical Diseases—But Not Ebola | Alex Lash | 09/10/14 | National |
| Mapp Bio Steps onto Global Stage as Ebola “Hot Zone” Gets Hotter | Bruce V. Bigelow | 08/29/14 | San Diego |
| BioCryst Bets on New Ebola Drug to Fight Bioterror, Outbreak Threats | Frank Vinluan | 07/24/14 | Raleigh Durham |
| Building Bridges in a New Global Health Landscape | Steve Davis | 06/04/12 | Seattle |
| Applied Hope | Amory Lovins | 02/21/12 | National |
| Eli Lilly Pumps $4M into IDRI to Continue Hunt for TB Drugs | Luke Timmerman | 11/17/11 | Seattle |
